ProSomnus, Inc. (OSAPQ)
Aug 6, 2024 - OSAPQ was delisted (reason: shares cancelled)
0.0140
+0.0004 (2.94%)
Inactive · Last trade price on Aug 5, 2024
ProSomnus Revenue
ProSomnus had revenue of $9.09M in the quarter ending June 30, 2024, with 31.12% growth. This brings the company's revenue in the last twelve months to $31.46M, up 33.69% year-over-year. In the year 2023, ProSomnus had annual revenue of $27.65M with 42.59% growth.
Revenue (ttm)
$31.46M
Revenue Growth
+33.69%
P/S Ratio
0.01
Revenue / Employee
$231,324
Employees
136
Market Cap
243.52K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 27.65M | 8.26M | 42.59% |
| Dec 31, 2022 | 19.39M | 5.32M | 37.79% |
| Dec 31, 2021 | 14.07M | 5.79M | 69.86% |
| Dec 31, 2020 | 8.29M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionOSAPQ News
- 1 year ago - ProSomnus® Sleep Technologies Announces Record Revenues as it Emerges from Reorganization - GlobeNewsWire
- 1 year ago - ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research Society - GlobeNewsWire
- 1 year ago - ProSomnus Announces Strong First Quarter 2024 Revenue Growth - GlobeNewsWire
- 1 year ago - ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting - GlobeNewsWire
- 1 year ago - Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices - GlobeNewsWire